Hypertrophic cardiomyopathy with left ventricular apical aneurysm: the newest high-risk phenotype
Authors:
- 27 November 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 21 (12) , 1351-1352
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Clinical Course and Management of Hypertrophic CardiomyopathyNew England Journal of Medicine, 2018
- Hypertrophic Cardiomyopathy With Left Ventricular Apical AneurysmJACC, 2017
- How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low MortalityJAMA Cardiology, 2016
- Phenotypic overlap in hypertrophic cardiomyopathy: Apical hypertrophy, midventricular obstruction, and apical aneurysmJournal of Cardiology, 2014
- A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathyHeart, 2013
- Apical Hypertrophic Cardiomyopathy With and Without AneurysmJACC, 2012
- Cardiac Magnetic Resonance in Hypertrophic CardiomyopathyJACC: Cardiovascular Imaging, 2011
- Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic CardiomyopathyCirculation, 2008
- Long-term outcome in patients with apical hypertrophic cardiomyopathyJACC, 2002
- Hypertrophic cardiomyopathy: When do you diagnose midventricular obstruction versus apical cavity obliteration with a small nonobliterated area at the apex of the left ventricle?JACC, 1992